Fri, October 14, 2022
Thu, October 13, 2022
Wed, October 12, 2022
Tue, October 11, 2022
Mon, October 10, 2022

Matthew Taylor Initiated (TNDM) at Strong Buy and Held Target at $75 on, Oct 12th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-75-on-oct-12th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Taylor of Jefferies, Initiated "Tandem Diabetes Care, Inc." (TNDM) at Strong Buy and Held Target at $75 on, Oct 12th, 2022.

Matthew has made no other calls on TNDM in the last 4 months.



There are 4 other peers that have a rating on TNDM. Out of the 4 peers that are also analyzing TNDM, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Matthew


  • Larry Biegelsen of "Wells Fargo" Downgraded from Buy to Sell and Decreased Target to $49 on, Tuesday, August 9th, 2022
  • Lawrence Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $82 on, Thursday, August 4th, 2022
  • Matt O'Brien of "Piper Sandler" Maintained at Buy with Decreased Target to $80 on, Thursday, August 4th, 2022
  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $90 on, Thursday, August 4th, 2022

Publication Contributing Sources